What is Endocrinology of Central Florida?
Operating within the competitive Physicians Clinics industry, Endocrinology of Central Florida provides specialized medical care with a focus on endocrine health. The company maintains a lean, high-impact workforce of 10 to 19 professionals, generating annual revenues in the range of 10M to 25M. This performance profile highlights the firm's efficiency and its critical role in delivering essential diagnostic and therapeutic services to its regional patient base. As a specialized provider, the company occupies a vital niche, balancing clinical excellence with sustainable business practices that appeal to debt-focused institutional partners.
How much funding has Endocrinology of Central Florida raised?
Endocrinology of Central Florida has raised a total of $384K across 2 funding rounds:
Debt
$150K
Debt
$234K
Debt (2020): $150K with participation from PPP
Debt (2021): $234K led by PPP
Key Investors in Endocrinology of Central Florida
PPP
Public-Private Partnership
What's next for Endocrinology of Central Florida?
With the recent influx of capital, Endocrinology of Central Florida is well-positioned to optimize its clinical infrastructure and expand its service delivery capabilities. The strategic deployment of these funds will likely focus on enhancing patient care technologies and potentially scaling its administrative operations to support a broader patient demographic. As the organization navigates the complexities of the healthcare landscape, this late-stage financing provides the necessary liquidity to pursue operational efficiencies and maintain its competitive edge in the Florida market. Future growth will likely be defined by the firm's ability to integrate these resources into its existing clinical framework while maintaining the high standards of care that have defined its market presence to date.
See full Endocrinology of Central Florida company page
